Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables Refunds
Ratios

Merit Medical Systems (MMSI) R&D In Process (2016 - 2023)

Merit Medical Systems' R&D In Process history spans 8 years, with the latest figure at $6.7 million for Q2 2022.

  • For Q2 2022, R&D In Process changed N/A year-over-year to $6.7 million; the TTM value through Sep 2023 reached $6.7 million, changed 0.37%, while the annual FY2023 figure was $1.5 million, 76.77% down from the prior year.
  • R&D In Process for Q2 2022 was $6.7 million at Merit Medical Systems, up from $25000.0 in the prior quarter.
  • Across five years, R&D In Process topped out at $6.7 million in Q2 2022 and bottomed at $25000.0 in Q1 2019.
  • The 3-year median for R&D In Process is $190500.0 (2018), against an average of $1.8 million.
  • The largest YoY upside for R&D In Process was 308.0% in 2018 against a maximum downside of 308.0% in 2018.
  • A 3-year view of R&D In Process shows it stood at $75000.0 in 2018, then crashed by 66.67% to $25000.0 in 2019, then skyrocketed by 26584.0% to $6.7 million in 2022.
  • Per Business Quant, the three most recent readings for MMSI's R&D In Process are $6.7 million (Q2 2022), $25000.0 (Q1 2019), and $75000.0 (Q3 2018).